177 related articles for article (PubMed ID: 16434211)
41. Role of NADPH-cytochrome P450 reductase and cytochrome-b5/NADH-b5 reductase in variability of CYP3A activity in human liver microsomes.
Gan L; von Moltke LL; Trepanier LA; Harmatz JS; Greenblatt DJ; Court MH
Drug Metab Dispos; 2009 Jan; 37(1):90-6. PubMed ID: 18838505
[TBL] [Abstract][Full Text] [Related]
42. Over-expression of ICE2 stabilizes cytochrome P450 reductase in Saccharomyces cerevisiae and Pichia pastoris.
Emmerstorfer A; Wimmer-Teubenbacher M; Wriessnegger T; Leitner E; Müller M; Kaluzna I; Schürmann M; Mink D; Zellnig G; Schwab H; Pichler H
Biotechnol J; 2015 Apr; 10(4):623-35. PubMed ID: 25641738
[TBL] [Abstract][Full Text] [Related]
43. Enhancement of cytochrome P-450 3A4 catalytic activities by cytochrome b(5) in bacterial membranes.
Yamazaki H; Nakajima M; Nakamura M; Asahi S; Shimada N; Gillam EM; Guengerich FP; Shimada T; Yokoi T
Drug Metab Dispos; 1999 Sep; 27(9):999-1004. PubMed ID: 10460798
[TBL] [Abstract][Full Text] [Related]
44. Studies on the interactions between drugs and estrogen: analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 with human NADPH-cytochrome P450 reductase.
Satoh T; Fujita KI; Munakata H; Itoh S; Nakamura K; Kamataki T; Itoh S; Yoshizawa I
Anal Biochem; 2000 Nov; 286(2):179-86. PubMed ID: 11067738
[TBL] [Abstract][Full Text] [Related]
45. Expression of bovine cytochrome P450c21 and its fused enzymes with yeast NADPH-cytochrome P450 reductase in Saccharomyces cerevisiae.
Sakaki T; Shibata M; Yabusaki Y; Murakami H; Ohkawa H
DNA Cell Biol; 1990 Oct; 9(8):603-14. PubMed ID: 2125425
[TBL] [Abstract][Full Text] [Related]
46. The effects of cytochrome b5, NADPH-P450 reductase, and lipid on the rate of 6 beta-hydroxylation of testosterone as catalyzed by a human P450 3A4 fusion protein.
Shet MS; Faulkner KM; Holmans PL; Fisher CW; Estabrook RW
Arch Biochem Biophys; 1995 Apr; 318(2):314-21. PubMed ID: 7733659
[TBL] [Abstract][Full Text] [Related]
47. Maximizing the expression of mammalian cytochrome P-450 monooxygenase activities in yeast cells.
Urban P; Cullin C; Pompon D
Biochimie; 1990; 72(6-7):463-72. PubMed ID: 2124149
[TBL] [Abstract][Full Text] [Related]
48. Expression of rat NADPH-cytochrome P-450 reductase cDNA in Saccharomyces cerevisiae.
Murakami H; Yabusaki Y; Ohkawa H
DNA; 1986 Feb; 5(1):1-10. PubMed ID: 3082610
[TBL] [Abstract][Full Text] [Related]
49. Do multiple cytochrome P450 isoforms contribute to parathion metabolism in man?
Mutch E; Daly AK; Leathart JB; Blain PG; Williams FM
Arch Toxicol; 2003 Jun; 77(6):313-20. PubMed ID: 12669189
[TBL] [Abstract][Full Text] [Related]
50. Stable Chinese Hamster Ovary Suspension Cell Lines Harboring Recombinant Human Cytochrome P450 Oxidoreductase and Human Cytochrome P450 Monooxygenases as Platform for In Vitro Biotransformation Studies.
Schulz C; Herzog N; Kubick S; Jung F; Küpper JH
Cells; 2023 Aug; 12(17):. PubMed ID: 37681872
[TBL] [Abstract][Full Text] [Related]
51. Cytochrome P450 reductase dependent inhibition of cytochrome P450 2B1 activity: Implications for gene directed enzyme prodrug therapy.
Lengler J; Omann M; Düvier D; Holzmüller H; Gregor W; Salmons B; Günzburg WH; Renner M
Biochem Pharmacol; 2006 Sep; 72(7):893-901. PubMed ID: 16887103
[TBL] [Abstract][Full Text] [Related]
52. [Expression and characterization of NADPH-cytochrome P450 reductase from Trametes versicolor in Escherichia coli].
Sun X; He C; Fang Z; Xiao Y
Sheng Wu Gong Cheng Xue Bao; 2018 Jul; 34(7):1156-1168. PubMed ID: 30058314
[TBL] [Abstract][Full Text] [Related]
53. Molecular cloning and expression in Saccharomyces cerevisiae of tobacco NADPH-cytochrome P450 oxidoreductase cDNA.
Yamada T; Imaishi H; Oka A; Ohkawa H
Biosci Biotechnol Biochem; 1998 Jul; 62(7):1403-11. PubMed ID: 9720224
[TBL] [Abstract][Full Text] [Related]
54. High levels of recombinant CYP3A4 expression in Chinese hamster ovary cells are modulated by coexpressed human P450 reductase and hemin supplementation.
Ding S; Yao D; Burchell B; Wolf CR; Friedberg T
Arch Biochem Biophys; 1997 Dec; 348(2):403-10. PubMed ID: 9434754
[TBL] [Abstract][Full Text] [Related]
55. Human cytochrome P450 expression in bacteria: Whole-cell high-throughput activity assay for CYP1A2, 2A6 and 3A4.
Esteves F; Campelo D; Urban P; Bozonnet S; Lautier T; Rueff J; Truan G; Kranendonk M
Biochem Pharmacol; 2018 Dec; 158():134-140. PubMed ID: 30308189
[TBL] [Abstract][Full Text] [Related]
56. The overexpression of CPR and P450 3A4 in pancreatic cancer cells changes the metabolic profile and increases the cytotoxicity and pro-apoptotic activity of acridine antitumor agent, C-1748.
Borowa-Mazgaj B; Mróz A; Augustin E; Paluszkiewicz E; Mazerska Z
Biochem Pharmacol; 2017 Oct; 142():21-38. PubMed ID: 28645477
[TBL] [Abstract][Full Text] [Related]
57. Expression, purification, and biochemical characterization of a human cytochrome P450 CYP2D6-NADPH cytochrome P450 reductase fusion protein.
Deeni YY; Paine MJ; Ayrton AD; Clarke SE; Chenery R; Wolf CR
Arch Biochem Biophys; 2001 Dec; 396(1):16-24. PubMed ID: 11716457
[TBL] [Abstract][Full Text] [Related]
58. Biotransformation of praziquantel by human cytochrome p450 3A4 (CYP 3A4).
Godawska-Matysik A; Kieć-Kononowicz K
Acta Pol Pharm; 2006; 63(5):381-5. PubMed ID: 17357589
[TBL] [Abstract][Full Text] [Related]
59. Reaction of human cytochrome P450 3A4 with peroxynitrite: nitrotyrosine formation on the proximal side impairs its interaction with NADPH-cytochrome P450 reductase.
Lin HL; Kenaan C; Zhang H; Hollenberg PF
Chem Res Toxicol; 2012 Dec; 25(12):2642-53. PubMed ID: 23016756
[TBL] [Abstract][Full Text] [Related]
60. Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.
McCarthy HO; Yakkundi A; McErlane V; Hughes CM; Keilty G; Murray M; Patterson LH; Hirst DG; McKeown SR; Robson T
Cancer Gene Ther; 2003 Jan; 10(1):40-8. PubMed ID: 12489027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
